Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether a history of severe hypoglycemia was associated with an increased risk of subsequent macrovascular events in people with type 2 diabetes and to explore possible mediation of this association by inflammation. RESEARCH DESIGN AND METHODS: A cohort of 1,066 adults aged 60–75 years with type 2 diabetes was evaluated prospectively. Baseline history of severe hypoglycemia and plasma levels of the inflammatory markers C-reactive protein, fibrinogen, interleukin-6, and tumor necrosis factor-α were recorded. Their association with incident macrovascular events after 4 years was explored. RESULTS: At baseline, 87 participants (8.2%) reported one or more episodes of severe hypoglycemia within the preceding year, and at follow-up 99 participants (9.3%) had suffered a new macrovascular event. Hypoglycemia was associated with increased odds of macrovascular events (odds ratio [OR] 2.11 [95% CI 1.06, 4.21], P = 0.035), including coronary heart events (OR 2.44 [95% CI 1.13, 5.26], P = 0.023), largely due to increased myocardial infarction (OR 4.02 [95% CI 1.54, 10.48], P = 0.004). Hypoglycemia was also associated with increased levels of inflammatory markers, including a general inflammation factor derived using principal-components analysis (P = 0.030, after adjustment for cardiometabolic risk factors). However, the significant association between hypoglycemia and macrovascular events persisted after adjustment for inflammatory markers. CONCLUSIONS: The odds of suffering a macrovascular event were higher in patients with type 2 diabetes who had a history of severe hypoglycemia. There was no evidence that a proinflammatory state had a major role in mediating this association.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [196]
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Microvascular and Macrovascular Complications of Diabetes
Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.2.77 · Cited by 1,954
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Cited by
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citationArnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch, I. B. (2015) · Diabetes Care · doi:10.2337/dc14-2898 · Cited by 282
“While there are numerous mechanisms by which hypoglycemia may result in poor macrovascular outcomes (13), hypoglycemia is in fact associated with both macrovascular and microvascular end points in type 2 diabetes (14,15),”
BackgroundLee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226
Davis, S. N., Duckworth, W., Emanuele, N., Hayward, R. A., Wiitala, W. L., Thottapurathu, L., Reda, D. J., & Reaven, P. D. (2019) · Diabetes Care · doi:10.2337/dc18-1144 · Cited by 126
Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 121
Self-citationKahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 122
Ceriello, A., Testa, R., & Genovese, S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.006 · Cited by 119
Yun, J., Park, Y., Han, K., Cha, S., Ahn, Y., & Ko, S. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0909-y · Cited by 99
Pistrosch, F., Ganz, X., Bornstein, S. R., Birkenfeld, A. L., Henkel, E., & Hanefeld, M. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0727-y · Cited by 74
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
Cha, S.-A., Yun, J.-S., Lim, T.-S., Hwang, S., Yim, E.-J., Song, K.-H., Yoo, K.-D., Park, Y.-M., Ahn, Y.-B., & Ko, S.-H. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.3.202 · Cited by 74
“Hypoglycemia has been suggested to have acute effects on sympathoadrenal activation, inflammation, increased platelet and neutrophil activation, coagulation, endothelial function, and inflammatory mediators or cytokines [22,25], all of which have potential adverse effects on myocardium or vascular hemodynamics [10,23].”
BackgroundMattishent, K., & Loke, Y. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.571568 · Cited by 69
“29 studies measured adverse events through database or medical records codes, one study relied on a professional interviewer with questionnaire (7) and one study on self-report/GP questionnaires (4).”
BackgroundInfluentialGoto, A., Goto, M., Terauchi, Y., Yamaguchi, N., & Noda, M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002875 · Cited by 67
“ADVANCE (2010), Asia, Australia/ New Zealand, Canada, Europe3 58 66 5.0 (median) 11 140 8 (mean) 2.1 VADT (2011), USA2 97 60 5.6 (median) 1791 11.5 (mean) 5.8 Johnston et al. (2011), USA30 51 61 1.0 (mean) 860 845 NA 3.1 Zhao et al. (2012), USA31 96 63 3.9 (median) 1522 NA 1.7 Rathmann et al. (2013), Germany32 53 67 2…”
BackgroundResultInfluentialAbdelrahim, D. N., Faris, M. E., Hassanein, M. M., Shakir, A. Z., Yusuf, A. M., Almeneessier, A. S., & BaHammam, A. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.624423 · Cited by 75
“7) Fasting + G18-53 (6-2) G2 7-03 (5-5) G3 7-05 (5-35) Ramadan fasting + Glibenclamide - Fructosamine - HbA1c - Body weight”
BackgroundMonnier, L., Colette, C., & Owens, D. R. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101225 · Cited by 63
Chun, K., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M., Cho, H., Choi, J., Lee, H., Hwang, K., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01720-4 · Cited by 57
Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus
Connelly, K. A., Yan, A. T.-K., Leiter, L. A., Bhatt, D. L., & Verma, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015946 · Cited by 54
Understanding the impact of hypoglycemia on the cardiovascular system
Davis, I., Ahmadizadeh, I., Randell, J., Younk, L. M., & Davis, S. N. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1275960 · Cited by 50
Joy, N. G., Perkins, J. M., Mikeladze, M., Younk, L., Tate, D. B., & Davis, S. N. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.030 · Cited by 33
“…(Aljada et al., 2004; Beckman, Creager, & Libby, 2002; Ceriello et al., 2013; Festa et al., 1999; Haubner et al., 2007) or hypoglycemia (Bedenis et al., 2014; Gogitidze Joy et al., 2010; Kvasnicka et al., 2000; Razavi Nematollahi et al., 2009; 52) can result in increased…”
Livingstone, R., Boyle, J. G., & Petrie, J. R. (2020) · Diabetic Medicine · doi:10.1111/dme.13911 · Cited by 34
Heller, S. R., Geybels, M. S., Iqbal, A., Liu, L., Wagner, L., & Chow, E. (2021) · Diabetologia · doi:10.1007/s00125-021-05556-7 · Cited by 37
Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
Tanner, M. J., Wang, J., Ying, R., Suboc, T. M. B., Malik, M. A., Couillard, A. B., Branum, A., Puppala, V. K., & Widlansky, M. E. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2016 · Cited by 34
“Exciting recent data show that exposure to a clinically relevant hypoglycemic condition, experimentally defined as a state of low-glucose (LG) concentration, results in vascular endothelial dysfunction, manifested by both vascular inflammation and impairment of nitric oxide (NO)-mediated, endothelium-dependent dilatio…”
BackgroundMuneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Clinical overview of diabetes mellitus as a risk factor for cardiovascular death
Abuelgasim, E., Shah, S., Abuelgasim, B., Soni, N., Thomas, A., Elgasim, M., & Harky, A. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2202038 · Cited by 32
“Interestingly however, one study noted that in patients with type 2 diabetes mellitus, severe hypoglycaemia carried a significant increase in the likelihood of experiencing a macrovascular event; however elevated proinflammatory markers were not predictive of subsequent events over a 4-year period [78].”
BackgroundSala, L. L., & Pontiroli, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910643 · Cited by 29
“Evidence reporting the link between hypoglycemia and cardiovascular disease has been emerged from large prospective randomized clinical trials [23,24] in which hypoglycemia was identified as the strongest predictor of macrovascular events, adverse clinical outcomes, and mortality in people with T2D.”
BackgroundSevere Hypoglycemia and Incident Heart Failure Among Adults With Type 2 Diabetes
Echouffo-Tcheugui, J. B., Kazé, A. D., Fonarow, G. C., & Dagogo-Jack, S. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab794 · Cited by 30
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management
Mancini, G. B. J., CHENG, A. Y. Y., Connelly, K. A., FITCHETT, D. H., Goldenberg, R., Goodman, S. G., Leiter, L. A., Lonn, E., Paty, B. W., Poirier, P., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.512 · Cited by 29
Time in range—A new gold standard in type 2 diabetes research?
Goshrani, A., Lin, R., O'Neal, D. N., & Ekinci, E. I. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16279 · Cited by 26
“56 An even looser target (>70% TIR at 5.0 – 10 mmol/L) was suggested for patients with renal or hepatic disease.”
InfluentialImpact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus
Jang, S. Y., Jang, J., Yang, D. H., Cho, H., Lim, S. K., Jeon, E., Lee, S. E., Kim, J., Kang, S., Baek, S. H., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01370-y · Cited by 23
Joy, N. G., Mikeladze, M., Younk, L. M., Tate, D. B., & Davis, S. N. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.001 · Cited by 24
“Recently the Edinburg Type 2 Diabetes Study has reported that hypoglycemia is associated with increased levels of inflammatory markers and is an independent risk factor for macro-vascular events [3].”
BackgroundThe Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?
Pop, L. M., & Lingvay, I. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0954-4 · Cited by 25
Liu, L., Liu, J., Xu, L., Ke, W., Wan, X., Li, H., He, X., Wang, L., Cao, X., Xiao, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12782 · Cited by 28
Xu, Y., Wang, Q., Wu, Z., Lu, K., Cheng, X., Jin, W., & Zhao, Y. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.019 · Cited by 21
Price, A. H., Weir, C. J., Welsh, P. I., McLachlan, S., Strachan, M. W. J., Sattar, N. A., & Price, J. F. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.07.009 · Cited by 21
“Given that these four biomarkers are highly correlated, it has been suggested that they may best be combined into one general factor, which describes the overall in fl ammatory burden [12,28 e 30].”
BackgroundSelf-citationAllo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Caldara, R., Tomajer, V., Monti, P., Sordi, V., Citro, A., Chimienti, R., Gremizzi, C., Catarinella, D., Tentori, S., Paloschi, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323439 · Cited by 20
Association between mild and severe hypoglycemia in people with type 2 diabetes initiating insulin
Festa, A., Heller, S. R., Seaquist, E. R., Duan, R., Hadjiyianni, I., & Fu, H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.12.014 · Cited by 20
Suárez‐Ortegón, M. F., McLachlan, S., Price, A. H., Fernández-Balsells, M., Franch‐Nadal, J., Mata‐Cases, M., Barrot, J., Mundet, X., Mauricio, D., Ricart, W., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.03.028 · Cited by 19
“described elsewhere for both studies (13-15)].”
Self-citationHypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance
Tanaka, K., Okada, Y., Torimoto, K., Nishio, K., Narisawa, M., & Tanaka, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-06450-x · Cited by 18
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 19
for the COSYCONET study group, Kahnert, K., Lucke, T., Biertz, F., Lechner, A., Watz, H., Alter, P. J., Bals, R., Behr, J., Holle, R., et al. (2017) · Respiratory Research · doi:10.1186/s12931-016-0499-0 · Cited by 17
Martínez-Ortega, A., Muñoz-Gómez, C., Gros-Herguido, N., Remón-Ruíz, P., Acosta-Delgado, D., Losada-Viñau, F., Pumar-López, A., Mangas-Cruz, M., González-Navarro, I., López-Gallardo, G., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041039 · Cited by 16
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14208 · Cited by 17
Choi, S.-Y., & Ko, S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.327 · Cited by 18
“SH is a strong predictor of major CV events and mortality in patients with T2DM [13-16], although it is unclear whether this is due to a direct pathophysiological association or whether SH acts as a marker of vulnerability to CV events.”
BackgroundRisk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14049 · Cited by 15
Washed microbiota transplantation reduces glycemic variability in unstable diabetes
Li, Y., Liu, Q., Zhang, L., Zou, J., He, R., Zhou, Y., Chen, Q., Zhu, Y., Chen, R., Zhang, Y., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13485 · Cited by 13
Yao, M.-Y., Li, L.-Q., Ma, J.-X., Xue, P., & Li, Y.-K. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198652 · Cited by 13
“Furthermore, GV is associated with both microvascular and macrovascular endpoints in type 2 diabetes (11).”
BackgroundKoracevic, G. P., Mićić, S., Stojanović, M., Tomasevic, M. V., Kostić, T. L., Koraćević, M., & Janković, I. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.09.004 · Cited by 14
He, A., Zuo, D., Liang, X., Guo, Y., Suxin, L., & Xia, Y. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104075 · Cited by 14
MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes
Ramanjaneya, M., Priyanka, R., Bensila, M., Jerobin, J., Pawar, K., Sathyapalan, T., Abou‐Samra, A., Halabi, N. M., Moin, A. S. M., Atkin, S. L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.917041 · Cited by 13
Hypoglycemia-induced changes in complement pathways in type 2 diabetes
Moin, A. S. M., Nandakumar, M., Diboun, I., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Atherosclerosis Plus · doi:10.1016/j.athplu.2021.11.002 · Cited by 10
Wang, L., Zhang, W., Dai, J., Deng, Q., Yan, Y., & Liu, Q. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14196 · Cited by 11
Mutailifu, S., Zhu, Q., Cai, X., Heizhati, M., Liu, S., Dang, Y., Wu, T. F., Hong, J., Lin, Y., & Li, N. (2024) · Journal of International Medical Research · doi:10.1177/03000605241291742 · Cited by 8
“33 Therefore, insulin use was included in the present multivariate models to adjust for its potential impact.”
Ghosal, S., Sinha, B., & Gangopadhyay, K. K. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.013 · Cited by 9
Jeon, H., Kim, W. H., Kim, B., & Shin, J. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13719 · Cited by 7
Ali, N., Janssen, A. W. M., Jaeger, M., de Wijer, L. V., van der Heijden, W., ter Horst, R., Vart, P., van Gool, A. J., Joosten, L. A. B., Netea, M. G., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14172 · Cited by 9
“Also, higher concentrations of circulating inflammatory markers have been reported in people with type 2 diabetes and a history of recurrent (severe) hypoglycaemia as compared to those without such a history.(25) These studies were relatively small and usually investigated only a few circulating cytokines.”
BackgroundLee, Y., Bae, Y., Kim, H., Park, J., Kwon, S. Y., Park, S., Kim, G., Hur, K. Y., Kim, J. H., & Jin, S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110083 · Cited by 7
Almomani, H. Y., Pascual, C., Al-Azzam, S. I., & Ahmadi, K. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.07.012 · Cited by 7
Cardiovascular Disease in Diabetes
Piché, M., & Poirier, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95793-3 · Cited by 7
Almomani, H. Y., Pascual, C., Grassby, P. F., & Ahmadi, K. (2022) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2022.09.017 · Cited by 8
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality
Bonaventura, A., Gallo, F., Carbone, F., Liberale, L., Maggi, D. C., Sacchi, G., Dallegri, F., Montecucco, F., & Cordera, R. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1094-7 · Cited by 6
Yoshikawa, F., Uchino, H., Nagashima, T., Usui, S., Miyagi, M., Ando, Y., Kumashiro, N., & Hirose, T. (2021) · Diabetology International · doi:10.1007/s13340-021-00513-6 · Cited by 7
Kaplan, H., Amod, A., Zyl, F. H. V., Reddy, J., van Tonder, A., Tsymbal, E., & McMaster, A. (2019) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2019.1608053 · Cited by 8
Haas, A. V., Koefoed, A. W., Easly-Merski, R., Celli, J., Heydarpour, M., Bonyhay, I., Freeman, R. L., & Adler, G. K. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-00983-5 · Cited by 6
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients
Bonaventura, A., Gallo, F., Carbone, F., Sacchi, G., Liberale, L., Dallegri, F., Maggi, D. C., Montecucco, F., & Cordera, R. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.008 · Cited by 4
Neue Therapieoptionen mit kontinuierlich gemessenen Glukosedaten – Empfehlungen für die Praxis
Seufert, J., Deiss, D., Gölz, S., Haak, T., Klausmann, G., Kroeger, J., Lobmann, R., Pfeiffer, A. F. H., Schnell, O., Seibold, A., et al. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0978-4537 · Cited by 4
“[46] Bedenis R, Price AH, Robertson CM et al.”
BackgroundYin, J., Han, M., Li, L., Li, Y., Liu, Z., Yang, J., & Liu, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s331833 · Cited by 4
Omar, M. A. K., Kok, A., Khutsoane, D., Joshi, S., Ramaboea, M., Mashitisho, M. L. I., Chetty, V., Koopman, L. J., Johnson, L., & on behalf of the IO HAT investigator group (2017) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2017.1385966 · Cited by 4
Sun, J., Xie, Z., Ye, M., He, X., Dong, Y., Liu, C., & Zhu, W. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14689 · Cited by 2
“32,34 In our study, the increased hospitalization rates associated with insulin-treated DM were observed in HFrEF patients during short-and long-term follow-ups.”
BackgroundГолубев, С. А. (2024) · Рецепт · doi:10.34883/pi.2024.27.1.002 · Cited by 2
Vergès, B. L. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.05.022 · Cited by 1
Schwere Hypoglykämien erhöhen Mortalität
Fritschka, E. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0871-7 · Cited by 1
Hypoglycemia among Insulin-treated Patients with Diabetes: Egypt Cohort of IO HAT Study
Hefnawy, M. H. M. F. E., Abdelaaty, T., Bassyouni, A., Saleem, H. M., Khalid, M., Toaima, D. N., & Maree, M. A. G. (2018) · The Open Diabetes Journal · doi:10.2174/1876524601808010034 · Cited by 1
GLYCAEMIA SELF-CONTROL ROLE IN PREVENTION OF CARDIOVASCULAR DISEASES IN DIABETES MELLITUS PATIENTS
Shatskaya, O. A., & Kukharenko, S. S. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-11-166-169
Raffali, M. A., Muhammad, S., Hamid, H. A., Nawi, A., & Kamaruddin, N. (2021) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.036.01.15
Control of Blood Glucose and Cardiovascular Risk Profile
Ciardullo, S., & Perseghin, G. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_28
Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes
Jenkins, A. J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_29
Clinical Outcomes of COVID-19 Patients with Controlled and Uncontrolled Diabetes Mellitus¥Preprint
Hodge, J., Gudlawar, S., Cavale, A. R., Patel, K., Patel, A., Tran, D., Dalal, S., Kavani, H., Parikh, U., Patel, U., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4798594
Chun, K.-H., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M.-S., Cho, H.-J., Choi, J.-O., Lee, H.-Y., Hwang, K.-K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604215
Chun, K.-H., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M.-S., Cho, H.-J., Choi, J.-O., Lee, H.-Y., Hwang, K.-K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604218
Chun, K.-H., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M.-S., Cho, H.-J., Choi, J.-O., Lee, H.-Y., Hwang, K.-K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604224
Chun, K.-H., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M.-S., Cho, H.-J., Choi, J.-O., Lee, H.-Y., Hwang, K.-K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604212
Chun, K.-H., Oh, J., Lee, C. J., Park, J. J., Lee, S. E., Kim, M.-S., Cho, H.-J., Choi, J.-O., Lee, H.-Y., Hwang, K.-K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604221
Jang, S. Y., Jang, J., Yang, D. H., Cho, H.-J., Lim, S., Jeon, E.-S., Lee, S. E., Kim, J.-J., Kang, S.-M., Baek, S. H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16590575
Mushins, A., Sauvé, C., & Parker, L. (2026) · Journal of Veterinary Dentistry · doi:10.1177/08987564251414451
Two threats in early life: congenital hyperinsulinemic hypoglycemia and thrombosis
Türktan, İ., Çetin, S. K., Şenyazar, G., Karaca, S. E., Abseyi, S. N., Demirtaş, Ş., Özsu, E., Aycan, Z., Berberoğlu, M., & Şıklar, Z. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261459825
“9,10 The higher frequency of hypoglycemic episodes in cases with thrombosis may be attributed to endothelial dysfunction and activation of the thrombotic cascade.”
Ajie, M., Ali, N., Hendriksz, M. S., Divilly, P., Rietveld, M. J., Abbink, E. J., Choudhary, P., Brøsen, J. M. B., Pedersen‐Bjergaard, U., McCrimmon, R. J., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71321
Metadata
- Authors
- Bedenis, R., Price, A. H., Robertson, C. M., Morling, J. R., Frier, B. M., Strachan, M. W. J., & Price, J. F.
- Affiliations
- University of Edinburgh (GB)
- Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland, U.K.
- Edinburgh Royal Infirmary (GB)
- Western General Hospital (GB)
- Corresponding author
- Bedenis, Rachel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-11-08
- Volume
- 37
- Issue
- 12
- Pages
- 3301-3308
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2157363221
- Cited by
- 87
- References
- 43
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 10 · 2022: 6 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 5 · 2017: 9 · 2016: 12 · 2015: 3
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, macrovascular events, myocardial infarction, coronary artery disease, inflammation, C-reactive protein, fibrinogen, interleukin-6, TNF-α, older adults
- MeSH terms
- Adult, Aged, C-Reactive Protein, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Hypoglycemia, Inflammation, Male, Middle Aged, Risk Factors, Tumor Necrosis Factor-alpha, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.